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Receptor-mediated increases in cytosolic Ca2+ in the human
erythroleukaemia cell line involve pertussis toxin-sensitive
and -insensitive pathways
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Institut fur Pharmakologie, Freie Universitat Berlin, Thielallee 69/73, 1000 Berlin 33, Germany
The pluripotent human erythroleukaemia cell line, HEL, possesses erythrocytic, megakaryocytic and macrophage-like
properties. With respect to signal transduction, HEL cells have been used as a model system for platelets, but little
attention has been paid to their phagocytic properties. We studied the effects of various receptor agonists on the
intracellular free Ca2l concentration ([Ca2l]1) in HEL cells. Thrombin, platelet-activating factor (PAF), ATP, UTP,
prostaglandins E1 and E2 (PGE1 and PGE2), the PGE2 analogue sulprostone and the stable PGI2 analogues iloprost and
cicaprost increased [Ca2+]'. ADP was less effective than ATP, and UDP was unable to increase [Ca2+]1. The increases in
[Ca2+]i induced by thrombin, PAF, ATP, UTP, iloprost and cicaprost were pertussis toxin-insensitive, whereas the
increases induced by PGE2 and sulprostone were completely inhibited by the toxin. The increase in [Ca2+]1 induced by
PGE1 was partially inhibited by pertussis toxin. PGE2 did not desensitize the increase in [Ca2+], induced by iloprost, and
vice versa. PGE1 desensitized the response to PGE2 and iloprost but not vice versa. Adrenaline potentiated the iloprost-
but not the PGE2-induced rise in [Ca2+]1. The phorbol ester phorbol 12-myristate 13-acetate completely blocked the rise
in [Ca2+]i induced by ATP and PGE1, whereas the increases induced by thrombin and PAF were only partially inhibited.
Agonists increased [Ca2+]! through release from internal stores and sustained Ca2+ influx. Thrombin stimulated Mn2+
influx, which was blocked by Ni2+. Diltiazem, isradipine, gramicidin and 1-{,f-[3-(4-methoxyphenyl)propoxy]-4-
methoxyphenethyl}- 1H-imidazole hydrochloride (SK&F 96365) did not affect agonist-induced rises in [Ca2+]i. HEL cells
contained substantial amounts of /-glucuronidase which, however, could not be released, and they did not aggregate or
generate superoxide. Our data suggest that: (1) HEL cells possess nucleotide receptors with properties similar to those of
phagocytes; (2) they possess receptors for PGE2 and PGI2, and PGE1 is an agonist at both receptors; (3) agonist-induced
increases in [Ca2+]i are mediated through pertussis toxin-sensitive as well as -insensitive signal transduction pathways; and
(4) agonists increase [Ca2+]i by mobilization from internal stores and influx from the extracellular space through cation
channels with properties similar to those of phagocytes and platelets.
INTRODUCTION
The human erythroleukaemia cell line HEL was derived from
a patient with Hodgkin's disease who developed erythro-
leukaemia in relapse [1]. HEL cells express markers for erythro-
cytes, megakaryocytes, myelomonocytes and B lymphocytes [1,2].
HEL cells are capable of spontaneous and induced globin
synthesis [1]. Phorbol 12-myristate 13-acetate (PMA) and
dimethyl sulphoxide induce additional macrophage-like and
megakaryocytic properties in HEL cells [3-8]. These cells express
various plasma membrane receptors, i.e. for a2-adrenergic agon-
ists, neuropeptide Y, prostaglandin I2 (PGI2), thromboxane A2,
thrombin, platelet-activating factor (PAF) and ADP [8-12].
HEL cells possess a-subunits of guanine-nucleotide-binding
proteins (G-proteins) of the G, family in relative abundances of
Gia2,> G1a3 > Gi.1 and the low-molecular-mass GTP-binding
protein rapl [13,14]. Adrenaline and neuropeptide Y mobilize
Ca2+ from intracellular stores by pertussis toxin-sensitive mech-
anisms, suggesting the involvement of G,-proteins in this process
[10,15,16]. Thrombin stimulates phospholipase C-catalysed in-
ositol phosphate generation and inhibits adenylate cyclase in a
pertussis toxin-sensitive manner [17]. The stable PGI2 analogue
iloprost stimulates adenylate cyclase and inhibits the thrombin-
and PAF-induced generations of inositol phosphates [8,14].
Thrombin stimulates an increase in the intracellular free Ca2+
concentration ([Ca2+]!) through a combination of intracellular
Ca2+ mobilization and Ca2+ influx [17]. In HEL cells, adrenaline,
thrombin, PAF and ADP activate phospholipase D, which may
be mediated by a rise in [Ca2+]i [12].
With respect to signal transduction, HEL cells have been used
as a model system for platelets, but little attention has been paid
to their phagocytic properties [7,8,11-17]. This prompted us to
study the effects of a broad variety of receptor agonists on [Ca2+]1
in HEL cells. We report here that ATP, UTP, PAF, thrombin
and E- and I-type prostaglandins increase [Ca2+]1 through mobil-
ization of intracellular stores and stimulate Ca2+ influx from the
extracellular space. The effects of E-type prostaglandins, but not
the other agonists studied, involve pertussis toxin-sensitive signal
transduction pathways.
MATERIALS AND METHODS
Materials
I1-{,-[3-(4-Methoxyphenyl)propoxy]-4-methoxyphenethyl}-
lH-imidazole hydrochloride (SK&F 96365) was a gift from Dr.
D. Arndts (Boehringer Ingelheim, Ingelheim, Germany); sulpro-
Abbreviations used: [Ca2"]1, intracellular free Ca2" concentration; Ca2"e, extracellular Ca2"; EC50, concentration causing 50 % of maximal
stimulation; G-protein, guanine-nucleotide-binding protein; G,, G-protein that inhibits adenylate cyclase; G., G-protein that stimulates adenylate
cyclase; HEL cells, human erythroleukaemia cells; PAF, platelet-activating factor (1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine); PGE1,
PGE2, E-type prostaglandins; PGI2, prostaglandin 12 (prostacyclin); U46619, 9,12-dideoxy-l l,9ac-epoxymethanoprostaglandin F2a; SK&F 96365,
1-{f,8-[3-(4-methoxyphenyl)propoxy]-4-methoxyphenethyl}-lH-imidazole hydrochloride; PMA, phorbol 12-myristate 13-acetate.
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stone, iloprost and cicaprost (ZK 96 480) were gifts from Dr.
E. Schillinger and Dr. K.-H. Thierauch (Schering, Berlin,
Germany); pertussis toxin was a gift from Dr. M. Yajima (Kyoto,
Japan). PGE1, PGE2, PGD2 and PGF2 , U46619, thrombin,
collagen and adrenaline were obtained from Sigma Chemie
(Deisenhofen, Germany). Sources of other materials have been
described elsewhere [18,19].
Cells and cell culture
HEL cells were purchased from the American Type Culture
Collection (Rockville, MD, U.S.A.). Cells were grown in RPMI
1640 medium containing fetal calf serum (10%, v/v), non-
essential amino acids (1 %, v/v), L-glutamine (2 mM), penicillin
(50 units/ml) and streptomycin (50 ,ug/ml) in a humidified at-
mosphere with 5 % CO2 at 37 'C. Cells were maintained at a
density of (0.5-1) x 106 cells/ml. In some experiments, pertussis
toxin (500 ng/ml) or its vehicle (control) were added to the
culture medium, and the cells were incubated for additional 24 h.
Under these conditions, the toxin completely ADP-ribosylates
pertussis toxin substrates in HEL cells [17]. Pertussis toxin did
not affect cell viability, as assessed by Trypan Blue exclusion
(results not shown).
Measurements of ICa2li
Measurement of [Ca21]1 was performed according to the
protocol described recently for HL-60 cells with modifications
[19]. Briefly, HEL cells were centrifuged (250 g, 10 min) and then
resuspended in buffer containing NaCl (138 mM), KCI (6 mM),
MgSO4 (1 mM), Na2HPO4 (1 mM), NaHCO3 (5 mM), glucose
(5.5 mM), Hepes/NaOH (20 mM), pH 7.4, and BSA (0.1 0%, w/v)
at 107 cells/ml. Fura-2/acetoxymethyl ester was added to a final
concentration of 4/tM, and cells were incubated for 10 min at
37 'C, protected from light. Thereafter, cells were diluted with
the same buffer to 5 x 106 cells/ml and were further incubated for
45 min at 37 'C. Subsequently, cells were diluted 10-fold with the
above buffer, then centrifuged (250 g, 10 min) and finally re-
suspended in fresh buffer at a concentration of 106 cells/ml and
stored at room temperature for up to 1 h. During this period,
experiments were performed. HEL cells (106 cells) were suspended
in 2 ml of the above buffer in the absence or the presence of
various compounds and were incubated for 2 min at 37 'C. Basal
fluorescence was measured for 1 min prior to the addition of
stimuli. Experiments were performed under constant stirring
(1000 rev./min) using a Ratio II spectrofluorometer (Aminco,
Silver Spring, MD, U.S.A.) at excitation and emission wave-
lengths of 340 nm and 500 nm respectively. Quenching of fura-2
fluorescence by Mn2+ was performed as described [20]. Unless
stated otherwise, all experiments were performed in the presence
of 1 mM-CaCl2. Basal [Ca2+]1 in HEL cells ranged from 120 to
230 nm (results not shown).
Assay of fi-glucuronidase release
HEL cells [(3-4) x 106 cells/tube] were suspended in 500,ul of
buffer containing NaCl (138 mM), KCI (6 mM), MgCl2 (1 mM),
CaCl2 (1 mM), glucose (5.5 mM) and Hepes/NaOH (20 mM),
pH 7.4, in the presence or absence of cytochalasin B (5,g/ml)
[19]. After preincubation of the HEL cells for 5 min at 37 °C,
stimuli were added. After 10 min of incubation, reactions were
terminated by placing the tubes on to crushed ice. Reaction
mixtures were centrifuged at 1000 g for 10 min at 4 'C, and the
activities of ,-glucuronidase and lactate dehydrogenase in the
supernatant fluids and cell lysates were determined as described
[21]. The release of lactate dehydrogenase amounted to < 5.0 %
of total cellular content, indicating that none of the agonists
studied caused cell damage (results not shown).
Continuous assay for superoxide formation
HEL cells [(2.5 or 5) x 106 cells/cuvette] were suspended in
500,l of the buffer used for determination of /8-glucuronidase
release, supplemented with ferricytochrome c (100,M) with or
without cytochalasin B (5 ,ug/ml) [18]. After preincubation of the
HEL cells for 3 min at 37 °C, stimuli were added and the
superoxide dismutase-inhibitable reduction of ferricytochrome c
was measured continuously at 550 nm for 10 min using an
Uvikon 810 spectrophotometer (Kontron, Eching, Germany).
Aggregation assay
Aggregation of HEL cells was measured by turbidometry as
described recently, with modifications [18]. Briefly, 0.5 x 107 or
1 x 107 cells were suspended in 1 ml of the buffer used for
determination of ,1-glucuronidase release. After incubation for
5 min at 37 °C in the presence of cytochalasin B (5 ,tg/ml) and
subsequent addition of the stimulus, aggregation was measured
under constant stirring (1000 rev./min) using an Uvikon 810
spectrophotometer.
Calculations and statistics
Calculations and curve plotting of the data shown in Figs. 1-4
were performed using GraphPAD v. 3.00, and non-linear re-
gression analysis was used to fit the curves and to calculate the
EC50 values (concns. causing 50 % of maximal stimulation).
Data shown in Figs. 1-4 are the means of assay triplicates. The
S.D. values of the experiments were generally < 100% of the
means. Similar results were obtained in at least three experiments
performed with different batches of HEL cells. Data shown in
Figs. 5-9 are representative of results obtained in at least three
independent experiments with different batches of HEL cells.
RESULTS
First, the effects of various purine and pyrimidine nucleotides
on [Ca2l], were studied. Both ATP and UTP increased [Ca2+]1 in
a concentration-dependent manner, with EC50 values of about
2 /SM and a plateau at 10-100 ivm (Fig. 1). Pertussis toxin did not
affect the rises in [Ca2+] induced by ATP and UTP. Adenosine
5'-[y-thio]triphosphate and ADP (10 /LM each) increased [Ca2+]1
with an effectiveness amounting to 65 % and 45 % respectively
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Fig. 1. Concentration-response curves of (a) UTP- and (b) ATP-induced
increases in ICa2+li in HEL cells
HEL cells were treated with pertussis toxin (0, 500 ng/ml) or its
vehicle (0, control) for 24 h. Thereafter cells were harvested and
loaded with fura-2, and the increases in ICa2J1i induced by UTP and
ATP at various concentrations were assessed.
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Fig. 2. Concentrationresponse curves of (a) sulprostone- and (b) PGE2-
induced increases in iCa2+li in HEL cells
HEL cells were treated with pertussis toxin (O, 500 ng/ml) or its
vehicle (0, control) for 24 h. Thereafter cells were harvested and
loaded with fura-2, and the increases in [Ca2+], induced by sulpro-
stone and PGE2 at various concentrations were assessed.
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Fig. 4. Concentration-response curves of (a) thrombin- and (b) PAF-
induced increases in ICa2"ii in HEL cells
HEL cells were treated with pertussis toxin (O, 500 ng/ml) or its
vehicle (-, control) for 24 h. Thereafter cells were harvested and
loaded with fura-2, and the increases in [Ca2"]i induced by thrombin
and PAF at various concentrations were assessed.
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Fig. 3. Concentration--response curves of(a)PGE,-and(b)ioprost-induced
increases in ICa2"ii in HEL ceLls
HEL cells were treated with pertussis toxin (0, 500 ng/ml) or its
vehicle (0, control) for 24 h. Thereafter cells were harvested and
loaded with fura-2, and the increases in [Ca2"], induced by PGE1 and
iloprost at various concentrations were assessed.
of that of ATP at an equimolar concentration. Adenosine,
AMP, adenosine 5'-[fi-thio]diphosphate, adenosine 5'-[a,,f-
methylene]triphosphate, adenosine 5'-[fl,y-methylene]triphos-
phate, adenosine 5'-[fi,y-imido]triphosphate, guanosine, GDP,
guanosine 5'-[/3-thio]diphosphate, GTP, guanosine 5'-[y-thio]-
triphosphate, ITP, UMP, uridylyl(3'-5')uridine, UDP, CMP,
CDP and CTP up to 100 1uM did not increase [Ca2+]1 (results not
shown).
The prostaglandins PGE1 and PGE2, the PGE2 analogue
sulprostone and the stable PGI2 analogues iloprost and cicaprost
all increased [Ca2+]1 in a concentration-dependent manner
[22-24]. The EC50 for PGE2 was 30 nm, and its effect reached a
maximum at 300 nM (Fig. 2). Sulprostone increased [Ca2+], with
an EC50 of 15 nm and a maximum at 1 /LM (see Fig. 2). Pertussis
toxin abolished the rises in [Ca2+1] induced by PGE2 and
sulprostone. The EC50 value for PGE1 was 120 nm, and the effect
was maximal at 1 ,uM (Fig. 3). Pertussis toxin partially inhibited
the rise in [Ca2+1] induced by PGE1 at submaximally and
maximally effective concentrations, and shifted the
concentration-response curve to the right (see Fig. 3). Iloprost
increased [Ca2+]i with an EC50 of 40 nm and a maximally effective
concentration of 1 /IM (see Fig. 3). The concentration-response
curve to cicaprost (results not shown) was virtually identical to
that of iloprost. Pertussis toxin did not affect the rise in [Ca2+]1
stimulated by iloprost (see Fig. 3) and cicaprost (results not
shown). Prostaglandins D2 and F2. (1 and 10 ,uM each) did not
increase [Ca21i1 (results not shown).
Thrombin increased [Ca2+]1 with an EC50 of 0.3 unit/ml and a
maximum at 1 unit/ml (Fig. 4). PAF stimulated an increase in
[Ca2+]1 with an EC50 of 6 nm and a maximum at 100 nm (Fig. 4).
Thrombin- and PAF-induced rises in [Ca2+]i were not affected by
pertussis toxin. The rank order of effectiveness of receptor
agonists at maximally effective concentrations in increasing
[Ca2+]1 was thrombin = PAF > UTP = ATP > sulprostone >
PGE2 = PGE1 > iloprost = cicaprost. Collagen (2,ug/ml) did
not increase [Ca2+]1 (results not shown).
Fig. 5 shows time courses of the increases in [Ca2+]i induced by
various agonists at maximally effective concentrations in the
presence or the absence of extracellular Ca2+ (Ca2+e). In the
presence of Ca2+e, ATP caused a rapid increase in [Ca2+]i to a
plateau which was maintained for at least 15 min. In the absence
of Ca2+e, the rise in [Ca2+]i was smaller, and [Ca2+], declined to the
baseline within 2 min. The time courses of the rises in [Ca2+]i
induced by UTP (results not shown) were almost identical to the
ones induced by ATP. In the presence of Ca2+e, PGE1 caused a
rapid rise in [Ca2+]i to a peak which declined slowly. In the
absence of Ca2+e, the magnitude of the rise in [Ca2+]i induced by
PGE1 was smaller, and [Ca2+]1 returned to the baseline value
within 1-2 min. Similar time courses as for PGE1 were observed
when HEL cells were stimulated with the other prostaglandins
(Fig. 6). In the presence of Ca2+e, thrombin and PAF induced
rapid increases in [Ca2+]1 which declined to the baseline within
6 min. In the absence of Ca2+e, both agonists induced less
prominent increases in [Ca2+]1, and resting values were reached
within 3 min.
The homologous and heterologous desensitization patterns of
the increases in [Ca2+1] induced by various prostaglandins (1 /M
each) were studied. When HEL cells were stimulated with PGE1,
PGE2, sulprostone, iloprost or cicaprost, re-addition of the same
agonist 3 min later did not result in a second rise in [Ca2+]1
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Fig. 5. Time courses of increases in ICa2"], in HEL cells induced by
thrombin, PAF, ATP and PGE1 in the presence and the absence of
Ca2+e
Cells were harvested and loaded with fura-2, and the increases in
[Ca2'+] induced by various agonists at the indicated concentrations
were assessed. Trace 1, experiments performed in the presence of
Ca2+e (1 mM); trace 2, experiments performed in the presence of
EGTA (1 mM). Superimposed original tracings are shown.
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Fig. 6. Heterologous desensitization of prostaglandin-induced increases in
ICa2+li in HEL cells
Cells were harvested and loaded with fura-2, and the increases in
[Ca2"], induced by prostaglandins were assessed. Arrows indicate
the addition of prostaglandins (I ,uM each). The second stimulus was
added 3 min after the first stimulus. Original tracings are shown.
(results not shown). PGE1 desensitized the response to PGE, and
iloprost (Fig. 6). In contrast, neither iloprost nor PGE2 desen-
sitized the response to PGE1. PGE2 did not desensitize the
increases in [Ca2+], induced by iloprost and vice versa. The
desensitization patterns of sulprostone and cicaprost (results not
shown) were identical to those ofPGE2 and iloprost respectively.
In human platelets, adrenaline enhances the increases in [Ca2+],
induced by agonists such as the thromboxane A2 analogue
Fig. 7. Time courses of increases in ICa2]i induced in HEL cells by
adrenaline, PGE2, iloprost and adrenaline plus PGE2 or iloprost
Cells were harvested and loaded with fura-2, and the increases in
[Ca21]i induced by the agonists were assessed. Arrows indicate the
addition of stimuli (10 mm each). Original tracings are shown.
U46619, thrombin and ADP [25]. In HEL cells, we examined the
effect of adrenaline at a threshold concentration (10 nM) on the
increase in [Ca2l], induced by various agonists at threshold
concentrations. Simultaneous addition of adrenaline and iloprost
(10 nM) resulted in a markedly higher increase in [Ca2+], than that
induced by either agonist alone (Fig. 7). Adrenaline did not
potentiate the increase in [Ca2+]i induced by PGE2 (10 nM) (Fig.
7). When added together with PGE1 (30 nM), PAF (5 nM),
thrombin (0.01 unit/ml), the thromboxane A2 analogue U46619
(10 nM), ATP, ADP or UTP (100 nm each), adrenaline failed to
enhance the increase in [Ca2+], induced by these agonists (results
not shown).
The effects of an activator of protein kinase C, PMA, on
increases in [Ca2+]i induced by agonists at maximally effective
concentrations were studied. PMA (100 nM) completely inhibited
the responses to ATP and PGE1 (Fig. 8), and diminished the
increases in [Ca2+], induced by thrombin and PAF. The increases
in [Ca2+]i induced by UTP, PGE2, sulprostone and iloprost were
also completely inhibited by PMA (results not shown). The
differential effects ofPMA suggest that protein kinase C inhibits
receptor-mediated rises in [Ca2+]i by interfering with early steps
of the signal transduction cascade, e.g. at the level of plasma
membrane receptors.
The cell-permeant analogue of cyclic AMP, dibutyryl cyclic
AMP (1 mM), did not in itself increase [Ca2+],, and did not affect
the rises in [Ca2+], induced by ATP, UTP, PGE2, sulprostone,
PGE1, iloprost, PAF or thrombin at submaximally and maxi-
mally stimulatory concentrations (results not shown).
SK&F 96365 was recently shown to inhibit receptor-mediated
Ca2+ influx in human platelets and neutrophils [26]. In HEL cells,
SK&F 96365 (10, 30 and 100 ltM) had no effect on the rise in
[Ca2+]i induced by thrombin (1 unit/ml) (results not shown). The
effect of membrane depolarization induced by gramicidins S and
D on rises in [Ca2+]i was examined. Neither gramicidin S
(100 nM) nor gramicidin D (1 UM) had any effect on resting
[Ca2+], or on the increase in [Ca2+], stimulated by thrombin (1
unit/ml) (result not shown). Additionally, the organic blockers
of voltage-gated Ca2+ channels, diltiazem (10 /tM) and isradipine
(1 /M), did not affect the thrombin-induced rise in [Ca2+], (results
not shown). The effects of the inorganic blockers of cation
channels, La2' and Ni2+, on agonist-induced rises in [Ca2+]i were
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Fig. 8. Time courses of increases in ICa2"Ii induced in HEL cells by
thrombin, PAF, ATP and PGE1: effect of PMA
Cells were harvested and loaded with fura-2, and the increases in
[Ca2+]1 induced by various agonists at the indicated concentrations
were assessed. Trace 1, experiments. performed. in the absence of
PMA; trace 2, experiments performed in the presence of PMA
(l00 nM). PMA was, added. to cells 3 min prior to stimuli. Super-
imposed original tracings are shown.
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Fig. 9. Effect of MNn2+ on fura-2 fluorescence of thrombin-stimulated HEL
cells
Cells were harvested and loaded with fura-2, and fura-2 fluorescence
was monitored at an excitation wavelength of 340 nm (trace 1) or
360 nm (trace 2). The emission wavelength was 500 nm. Experiments
were performed in the absence of Ca2"e. The arrows indicate the
addition of MnCl2 (100 /LM) and thrombin (1 unit/ml). (a) Experi-
ments in the absence of NiCl2, (b) experiments in the presence of
NiCl2 (5 mM). NiCl2 was added to cells 2 min prior to MnCl2.
Superimposed original tracings are shown.
examined. LaCl2 (1 mM) did not affect resting or thrombin-
induced increases in [Ca211 (results not shown). By contrast,
NiCl2 (5 mM) decreased the effect of thrombin (1 unit/ml) to that
seen in the absence of Ca2+e (see Fig. 5) (results not shown).
In order to answer the question ofwhether thrombin stimulated
influx of bivalent cations, quenching of fura-2 fluorescence by
Mn2+ was studied. At an excitation wavelength of 340 nm,
fluorescence is increased by Ca2+and decreased by Mn2+. At an
excitation wavelength of 360 nm, fluorescence is again quenched
by Mn2+, but is insensitive to Ca2+ [20]. At both excitation
wavelengths, Mn2+ induced a slow decrease in fluorescence,
indicating basal Mn2+ influx (Fig. 9). At an excitation wavelength
of 340 nm, thrombin (1 unit/ml) transiently increased fluor-
escence, reflecting release of Ca2+ from internal stores. At an
excitation wavelength of 360 nm, thrombin substantially
increased fluorescence quenching. Ni2+blocked the latter process,
but not the transient increase in fluorescence at 340 nm (Fig. 9).
In order to assess the functional role of agonist-induced rises
in [Ca2+1], fl-glucuronidase release, superoxide formation and cell
aggregation were measured. The total activity of ,-glucuronidase
in HEL cells amounted to 0.07 + 0.01 nmol min-' 106 cells-1
(n = 3), a value comparable with that of human neutrophils [21].
Thrombin, ATP, UTP and PGE1, employed at concentrations
that were maximally or supramaximally effective in increasing[Ca2+]1, did not activate any of the above-mentioned functions.
Additionally, PMA (100 nM) did not stimulate superoxide for-
mation or cell aggregation in HEL cells (results not shown).
DISCUSSION
We studied the effects of various nucleotides on [Ca2+]1 in HEL
cells. The order of effectiveness of adenine nucleotides, at
maximally effective concentrations, in increasing [Ca2+1] (ATP >
adenosine 5'-[y-thio]triphosphate > ADP) suggests that their
effects are mediated via P2 -like purinoceptors. This assumption
is supported by the finding that adenosine, AMP, adenosine 5'-
[a,fi-methylene]triphosphate and adenosine 5'-[fl,y-methylene]-
triphosphate did not increase [Ca2+]1 in these cells [27,28].
UTP was found to be equipotent and as effective as ATP in
increasing [Ca2+]1 in HEL cells (Fig. 1). In the pluripotent
promyelocytic human cell line HL-60, the relative effectiveness of
nucleotides in increasing [Ca2+]1 is similar to that in HEL cells
[29]. In undifferentiated and differentiated HL-60 cells, pertussis
toxin partially inhibits the increase in [Ca2+1] induced by ATP,
adenosine 5'-[y-thio]triphosphate and UTP [19,30]. These find-
ings suggest the involvement of both pertussis toxin-sensitive and
-insensitive G-proteins in signal transduction pathways activated
by nucleotides in HL-60 cells. In HEL cells, pertussis toxin had
no effect on either ATP- or UTP-induced rises in [Ca2+]1 (Fig. 1).
Similar to its effect in HL-60 cells, PMA completely inhibited
nucleotide-induced rises in [Ca2+1] in HEL cells (See Fig. 8) [30].
In HL-60 cells, stimulatory effects of UTP were suggested to be
mediated through pyrimidinoceptors [31]. The fact that ADP
increased [Ca2+]1 in HEL cells, whereas UDP did not, suggests
that in these cells UTP also acts through pyrimidinoceptors.
The order of effectiveness of nucleotides in activating HEL cells is
dissimilar to that in platelets. In the latter cells, ATP and UTP
are competitive antagonists for ADP, and ADP is the most
effective nucleotide for platelet activation [27]. Also dissimilar to
platelets, adrenaline did not potentiate the increase in [Ca2"],
induced by ADP in HEL cells [25]. All these data suggest that
HEL cells possess phagocyte-like nucleotide receptors coupled to
pertussis toxin-insensitive G-proteins.
It is well known that receptors for PGO2 mediate activation of
adenylate cyclase, with a subsequent increase in cyclic AMP, in
various cell types including platelets, vascular smooth muscle
cells, mastocytoma cells and HEL cells [8,24,32-34]. Most
unexpectedly, we found that iloprost and cicaprost increased[Ca21], as did PGE, PGE and sulprostone (Figs. 2 and 3).
However, iloprost does not only act as agonist at PG12 receptors,
but also at PGE2 receptors [23,24]. Our data indicate that the E2-
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type prostaglandins on the one hand and the PGI2 analogues on
the other increased [Ca2+]1 through different receptors. The
increases in [Ca2+]i induced by PGE2 and sulprostone were
completely inhibited by pertussis toxin, whereas the toxin did not
affect the increases in [Ca2+], induced by iloprost and cicaprost.
The former finding suggests involvement of G.-proteins, and the
latter finding suggests that the PGI2 receptor couples to a G-
protein that is different from Gil Additionally, the E2-type
prostaglandins did not desensitize the response to iloprost or
cicaprost, and vice versa (see Fig. 6). Moreover, adrenaline
enhanced the increases in [Ca2+]1 stimulated by iloprost but not
by PGE2 (Fig. 7). Furthermore, cicaprost is devoid of agonist
activity at PGE2 receptors [23,24]. To our knowledge, stimulatory
effects of PGI2 analogues on [Ca2+]i have not been observed.
Whether the effects of iloprost and cicaprost in HEL cells are
attributable to the presence of a PGI2 receptor subtype or to
tumour-cell-associated aberrations in the interactions of recep-
tors with G-proteins and/or effector systems remains to be
determined. It will also be of interest to study the effects of PGI2
analogues on [Ca2+]i in normal haemopoietic progenitor cells.
In contrast to PGE2 and the PGI2 analogues, which apparently
increased [Ca2+]1 through different receptors, PGE1 mimicked the
effects of both of these agonists. This suggests that PGE1 activates
both of the above receptors. This notion is supported by the
following findings. The increase in [Ca2+]i induced by PGE1 was
partially inhibited by pertussis toxin (Fig. 3). This suggests
involvement of different G-proteins, one of them being GC.
Additionally, PGE1 desensitized the response to PGE2 and
iloprost or cicaprost, but there was no reciprocal effect. By
analogy, PGEl-induced vasodilation also involves stimulation of
PGE2 and PGI2 receptors [35].
In human platelets, various prostaglandins such as PGE1 and
PGI2 cause a GC-protein-mediated stimulation of adenylate
cyclase [32]. This process is assumed to play a role in inhibition
of platelet activation, including receptor-mediated rises in [Ca2+]i[32]. In agreement with the data obtained for platelets, iloprost
inhibits thrombin- and PAF-induced inositol phosphate gen-
eration [14]. Apparently, the stimulatory effects ofprostaglandins
on [Ca2+]i in HEL cells are not mediated through an increase in
cyclic AMP, as dibutyryl cyclic AMP failed to mimic their
effects. Additionally, the prostaglandin-mediated increases in
[Ca2"], were not affected by a rise in cyclic AMP. Thus stimulatory
effects of prostaglandins in HEL cells on cyclic AMP on the one
hand and on [Ca2+]1 on the other may be independently regulated.
Similar to the situation in HEL cells, PGE2 was reported to
increase [Ca2+]i in HL-60 cells, and this effect was not mimicked
by a cell-permeant analogue of cyclic AMP [36]. Unlike in HEL
cells, the effect of PGE2 in HL-60 cells was pertussis toxin-
insensitive, and the effects of PGI2 analogues were not investi-
gated [36].
Among all the agonists studied, thrombin and PAF were the
most effective. In contrast to inositol phosphate generation, the
thrombin-induced increase in [Ca2+]i was pertussis toxin-in-
sensitive (Fig. 4) [17]. Intriguingly, pertussis toxin completely
blocked the thrombin-induced inhibition of adenylate cyclase
and greatly decreased but did not abolish thrombin-stimulated
inositol phosphate generation [17]. Thus it is possible that the
residual inositol phosphate generation was sufficient to increase
[Ca2+]I.
In HEL cells, thrombin, PAF, ATP, UTP and the prosta-
glandins increased [Ca2+]i through both mobilization from inter-
nal stores and sustained Ca2+ influx (Fig. 5). We studied the
effects of various drugs on the agonist-induced increases in
[Ca2+]i to evaluate the properties of the channel which mediated
the Ca2+ influx. The lack of effect of diltiazem and isradipine on
rises in [Ca2+]i argues against the presence of voltage-gated Ca2+
channels in HEL cells, and this finding is in agreement with
earlier published results on platelets and neutrophils [37,38].
Additionally, gramicidin S and D did not affect the agonist-
induced rise in [Ca2+]i in HEL cells. In platelets, gramicidin D
inhibits thrombin-induced Ca2+ influx, whereas in neutrophils
gramicidin D does not affect a formyl-peptide-induced increase
in [Ca2+] [38,39]. The finding that SK&F 96365 did not affect the
increase in [Ca2+]i in HEL cells does not argue against the
presence of receptor-stimulated cation channels in these cells.
SK&F 96365 may discriminate between different types of re-
ceptor-stimulated cation channels. In platelets and neutrophils,
SK&F 96365 blocks Ca2+ influx, but it is ineffective in blocking
ATP-linked Ca2+ channels in rabbit artery smooth muscle and in
the human neurosecretory cell line PC12 [26,40]. Similar to
neutrophils, HL-60 cells and platelets, there is receptor-mediated
Mn2+ influx in HEL cells which is blocked by Ni2+ (Fig. 8)
[20,36,38,41-43]. These data show that HEL cells possess re-
ceptor-stimulated cation channels with properties similar but not
identical to those in other myelocytic cells.
An increase in [Ca2+] is known to play a role in the regulation
of numerous cell functions [32,44]. In HEL cells, we found a
dissociation between agonist-induced rises in [Ca2+]i on the one
hand and ,8-glucuronidase release, superoxide formation and cell
aggregation on the other hand. Interestingly, the specific ,-
glucuronidase activity in HEL cells was found to be similar to
that in human neutrophils [21], but in contrast to the situation
with these latter cells, 8-glucuronidase could not be released by
agonists. In undifferentiated and differentiated HL-60 cells, ATP
and UTP increase [Ca2+]i, but only in the differentiated cells do
they induce ,J-glucuronidase release [19]. HEL cells did not
generate superoxide upon stimulation, similar to the situation
with undifferentiated HL-60 cells [19]. In platelets and neutro-
phils, increases in [Ca2+]i may be prerequisites for receptor-
mediated aggregation [32,45]. In HEL cells, thromboxane A2
induced a shape change but no aggregation [11]. The dissociations
between rises in [Ca2+]i and lack of functional activation in HEL
cells suggest that proximal signal transduction components are
present in these cells, whereas components of the distal signal
transduction pathway and/or effector proteins are missing. It is
conceivable that these distal components are expressed during
the later stages of megakaryocytic and myelocytic differentiation.
Possibly the PGE2- and ATP-induced increases in [Ca2+1] are
early signals for the differentiation of HEL cells, as in HL-60 cells
these agonists promote myeloid differentiation [46,47]. Regard-
less of the functional role, the differences in the time courses and
amplitude of rises in [Ca2+]i induced by various agonists in HEL
cells indicate that they may be non-equivalent.
In conclusion, HEL cells possess a number of receptors which
mediate increases in [Ca2+]i through pertussis toxin-sensitive and
-insensitive pathways. Receptor agonists increase [Ca2+]i by
mobilization from internal stores and influx from the extracellular
space through receptor-stimulated cation channels with proper-
ties similar to those of phagocytes and platelets. Thus HEL cells
may be a valuable system for investigating thrombocytic and
phagocytic aspects of signal transduction and differentiation.
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Note added in proof (received 28 October 1991)
After submission of this paper, Wu et al. [48] reported that
PGE1 and PGE2 activated phospholipase D in HEL cells in a
pertussis-toxin-sensitive manner.
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